XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 22 $ 9 $ (433) $ 154,401 $ 2 $ (189,784) $ (35,783)
Balance, shares at Dec. 31, 2022 22,094,889 9,126,726 (433,333)        
Stock compensation 982 982
Fair value of vested restricted stock units 774 774
Fair value of vested restricted stock units, shares   113,500          
Cost of stock option modifications and repricing 2,667 2,667
Net loss (21,530) (21,530)
Issuance of common shares upon exercise of stock warrants $ 1 2,740 2,741
Issuance of common shares upon exercise of stock warrants, shares   430,086          
Issuance of common shares upon exercise of stock options 1,321 1,321
Issuance of common shares upon the closing of private financings, net of offering costs $ 2 25,140 25,142
Issuance of common shares upon the closing of private financings, net of offering costs, shares   1,292,079          
Conversion of notes payable-shareholders and accrued interest 1,865 1,865
Fair value of warrants issued in connection with the conversion of convertible notes payable 3,152 3,152
Issuance of common shares upon the closing of the initial public offering, net of offering costs $ 3 12,629 12,632
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares   2,653,000          
Issuance of common shares upon conversion of preferred stock $ (22) $ 8 14
Issuance of common shares upon conversion of preferred stock, shares (22,094,889) 8,355,610          
Issuance of common shares upon conversion of convertible notes payable, accrued interest and loan fees $ 4 29,892 29,896
Issuance of common shares upon conversion of convertible notes payable, accrued interest and loan fees, shares   4,134,367          
Issuance of common shares upon conversion of preferred stock dividends payable 3,443 (3,443)
Issuance of common shares upon conversion of preferred stock dividends payable, shares   272,101          
Reclassification of warrant liabilities upon the closing of the initial public offering 169 169
Conversion of notes payable-shareholders and accrued interest, shares   73,134          
Balance at Sep. 30, 2023 $ 27 $ (433) 239,189 2 (214,757) 24,028
Balance, shares at Sep. 30, 2023 26,657,906 (433,333)        
Balance at Dec. 31, 2022 $ 22 $ 9 $ (433) 154,401 2 (189,784) (35,783)
Balance, shares at Dec. 31, 2022 22,094,889 9,126,726 (433,333)        
Net loss             (28,297)
Balance at Dec. 31, 2023 $ 27 $ (433) 241,389 14 (221,524) 19,473
Balance, shares at Dec. 31, 2023 26,788,986 (433,333)        
Balance at Jun. 30, 2023 $ 26 $ (433) 232,073 2 (209,412) 22,256
Balance, shares at Jun. 30, 2023 25,855,511 (433,333)        
Stock compensation 515 515
Fair value of vested restricted stock units 147 147
Fair value of vested restricted stock units, shares   113,500          
Cost of stock option modifications and repricing 25 25
Net loss (5,345) (5,345)
Issuance of common shares upon exercise of stock warrants $ 1 1,566 1,567
Issuance of common shares upon exercise of stock warrants, shares   306,592          
Issuance of common shares upon exercise of stock options 1,321 1,321
Issuance of common shares upon exercise of stock options, shares   207,303          
Issuance of common shares upon the closing of private financings, net of offering costs 3,500 3,500
Issuance of common shares upon the closing of private financings, net of offering costs, shares   175,000          
Conversion of notes payable-shareholders and accrued interest
Fair value of warrants issued in connection with the conversion of convertible notes payable 42 42
Balance at Sep. 30, 2023 $ 27 $ (433) 239,189 2 (214,757) 24,028
Balance, shares at Sep. 30, 2023 26,657,906 (433,333)        
Balance at Dec. 31, 2023 $ 27 $ (433) 241,389 14 (221,524) 19,473
Balance, shares at Dec. 31, 2023 26,788,986 (433,333)        
Stock compensation 4,308 4,308
Unrealized gain on short and long-term investments 110 110
Fair value of vested restricted stock units 1,352 1,352
Fair value of vested restricted stock units, shares   156,810          
Cost of stock option modifications and repricing 326 326
Net loss (20,893) (20,893)
Issuance of common shares upon exercise of stock warrants $ 8 27,670 27,678
Issuance of common shares upon exercise of stock warrants, shares   7,500,000          
Issuance of common stock in connection with the Company’s equity award programs 49 49
Issuance of common stock in connection with the Company's equity award programs, shares   15,902          
Issuance of common shares upon exercise of stock options 688 $ 688
Issuance of common shares upon exercise of stock options, shares   76,487        
Balance at Sep. 30, 2024 $ 35 $ (433) 275,782 124 (242,417) $ 33,091
Balance, shares at Sep. 30, 2024 34,538,185 (433,333)        
Balance at Jun. 30, 2024 $ 35 $ (433) 274,028 (11) (235,950) 37,669
Balance, shares at Jun. 30, 2024 34,512,642 (433,333)        
Stock compensation 1,521 1,521
Unrealized gain on short and long-term investments 135   135
Fair value of vested restricted stock units 227 227
Fair value of vested restricted stock units, shares   25,543          
Cost of stock option modifications and repricing 6     6
Net loss (6,467) (6,467)
Balance at Sep. 30, 2024 $ 35 $ (433) $ 275,782 $ 124 $ (242,417) $ 33,091
Balance, shares at Sep. 30, 2024 34,538,185 (433,333)